en en fi en en en en en fr en en en en en en en en en en en en en en en en en en en en en he en en en en en en en en en en en ro it en eu en en en en en en en en en en en en en en en en en en en en en en en en en en en en en it en en en en en en en en en en en
NeuroLogica announced the commercial availability of the SmartMSU with OmniTom Elite CT scanner, a mobile stroke unit (MSU) that builds on the technology the company released a decade ago. Equipped with the small footprint OmniTom Elite multi-slice CT, the unit and scanner are designed to optimize diagnostic confidence, speed and workflow at the site for a potential stroke patient.
The small size of the OmniTom Elite within the SmartMSU™ maintains the standard footprint of the ambulance and allows for normal workflow for EMTs throughout the vehicle. A safety mechanism securing OmniTom to the vehicle creates additional space around the scanner and internal radiation shielding helps reduce scatter, providing additional protection to staff.
OmniTom Elite enables the integration of contrast injectors for optimized workflow when performing CT angiography and CT perfusion, allowing for initiation of scanning and timing of contrast to be performed by the injector. In addition, a redesigned radiolucent interface for the onboard stretcher allows for minimal movement of the patient when positioning them for head imaging. The OmniTom Elite is designed for low-power consumption and to be battery operated, minimizing charging that may help lengthen the time on the road.
“NeuroLogica has a long and proud history of delivering healthcare providers and patients access to mobile, point-of-care, technology that can help save lives,” said David Webster, Chief Operating Officer, NeuroLogica. “We’re thrilled to build off of our expertise, and outfit ambulances with the OmniTom Elite mobile CT to further advance patient care.”
Neurological and Orbital Involvement of Systemic IgG4-related Sclerosing Disease
Brought to you by Guerbet. Case Summary A 70-year-old male...
Reflecting on the Impact of COVID-19, the Influence of Applied Radiology, and the Future of Neuroradiology